Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,726
Talazoparib and Thoracic RT for ES-SCLC
for
Lung Cancer, Small-Cell Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT04170946
Phase 1, Recruiting
Bilateral Essential Tremor Treatment With Gamma Knife
for
Essential Tremor
Location: Sherbrooke, Toronto
Sponsor: Université de Sherbrooke
Sex: All
Age: 18+
Code: NCT04748640
Phase 2, Phase 3, Recruiting
Video Stylet vs. Flexible Bronchoscopy for C-Spine
for
Intubation;Difficult, Intubation Complication
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18 - 70+
Code: NCT03992092
Recruiting
Electronically Connected Health Coaching in Type 2 Diabetes
for
Type 2 Diabetes
Location: Toronto
Sponsor: York University
Sex: All
Age: 18 - 70+
Code: NCT02036892
Phase 3, Recruiting
Exercise in Patients With End Stage Kidney Disease
for
Renal Failure
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute
Sex: All
Age: 18+
Code: NCT03787589
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Virtual Rehabilitation for Cancer Survivors
for
Breast Cancer, Stage 0, Colorectal Cancer Stage I,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05898789
Recruiting
MR Guidance for Liver and Pancreas
for
Magnetic Resonance Imaging
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT03582189
Recruiting
Clinical Study Of The Bionode System In Subjects With Elevated IOP
for
Unmedicated IOP Before and After Treatment
Location: Oakville
Sponsor: Bionode, LLC
Sex: All
Age: 22+
Code: NCT04093089
Recruiting
Power Over Pain Portal: A Stepped-care Virtual Solution to Deliver Early Intervention to Canadian Youth With Chronic Pain
for
Chronic Pain
Location: Toronto
Sponsor: The Hospital for Sick Children
Sex: All
Age: 12 - 18
Code: NCT06076889
Recruiting
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
for
Spinal Cord Injury, Spinal Cord Injury at C5-C7 Level,
Location: Halifax, Kingston, Toronto, Vancouver
Sponsor: University of British Columbia
Sex: All
Age: 18 - 70
Code: NCT05638191
Recruiting
Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol
for
Diabetes, Graft Rejection
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18 - 70
Code: NCT00706680
Recruiting
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
for
Breast Neoplasms, Breast Cancer
Location: Boston MA, New Brunswick NJ, Montreal, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06686394
Phase 1, Phase 2, Recruiting
Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)
for
Localized Prostate Cancer, Stereotactic Body Radiotherapy
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Male
Age: 18+
Code: NCT06825091
Phase 3, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Boston MA, Mineola NY, New York NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD
for
Alpha-1 Antitrypsin Deficiency
Location: Toronto
Sponsor: Wave Life Sciences USA, Inc.
Sex: All
Age: 18 - 70
Code: NCT06405633
Phase 1, Phase 2, Recruiting
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection